Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 636

1.

Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.

Reavis KM, Morris CD, Gopal DV, Hunter JG, Jobe BA.

Ann Surg. 2004 Jun;239(6):849-56; discussion 856-8.

2.

Gastroesophageal reflux disease, proton-pump inhibitor use and Barrett's esophagus in esophageal adenocarcinoma: Trends revisited.

Lada MJ, Nieman DR, Han M, Timratana P, Alsalahi O, Peyre CG, Jones CE, Watson TJ, Peters JH.

Surgery. 2013 Oct;154(4):856-64; discussion 864-6. doi: 10.1016/j.surg.2013.07.020.

PMID:
24074425
3.

Risk factors in the development of esophageal adenocarcinoma.

Pohl H, Wrobel K, Bojarski C, Voderholzer W, Sonnenberg A, Rösch T, Baumgart DC.

Am J Gastroenterol. 2013 Feb;108(2):200-7. doi: 10.1038/ajg.2012.387. Epub 2012 Dec 18.

PMID:
23247577
4.

Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.

Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA.

Ann Thorac Surg. 2005 May;79(5):1716-23.

PMID:
15854962
5.

[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].

Endzinas Z, Mickevicius A, Kiudelis M.

Zentralbl Chir. 2004 Apr;129(2):99-103. German.

PMID:
15106039
6.

Symptoms, acid exposure and motility in patients with Barrett's esophagus.

Brandt MG, Darling GE, Miller L.

Can J Surg. 2004 Feb;47(1):47-51.

7.
8.

Prevalence and predictors of columnar lined esophagus in gastroesophageal reflux disease (GERD) patients undergoing upper endoscopy.

Balasubramanian G, Singh M, Gupta N, Gaddam S, Giacchino M, Wani SB, Moloney B, Higbee AD, Rastogi A, Bansal A, Sharma P.

Am J Gastroenterol. 2012 Nov;107(11):1655-61. doi: 10.1038/ajg.2012.299. Epub 2012 Oct 2.

PMID:
23032983
9.

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.

Avidan B, Sonnenberg A, Schnell TG, Chejfec G, Metz A, Sontag SJ.

Am J Gastroenterol. 2002 Aug;97(8):1930-6.

PMID:
12190156
10.

Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies.

Rubenstein JH, Scheiman JM, Sadeghi S, Whiteman D, Inadomi JM.

Am J Gastroenterol. 2011 Feb;106(2):254-60. doi: 10.1038/ajg.2010.470. Epub 2010 Dec 7.

13.

Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia.

Velanovich V, Hollingsworth J, Suresh P, Ben-Menachem T.

Dig Surg. 2002;19(5):349-53.

PMID:
12435904
14.

Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review.

Shaheen N, Ransohoff DF.

JAMA. 2002 Apr 17;287(15):1972-81. Review.

PMID:
11960540
15.

Esophageal motor function in laryngopharyngeal reflux is superior to that in classic gastroesophageal reflux disease.

Postma GN, Tomek MS, Belafsky PC, Koufman JA.

Ann Otol Rhinol Laryngol. 2001 Dec;110(12):1114-6.

PMID:
11768699
16.

The diagnosis and management of Barrett's esophagus.

DeMeester SR, DeMeester TR.

Adv Surg. 1999;33:29-68. Review.

PMID:
10572561
17.

Gastroesophageal reflux and cancer.

Turcotte S, Duranceau A.

Thorac Surg Clin. 2005 Aug;15(3):341-52. Review.

PMID:
16104125
18.

Recent advances in oesophageal diseases.

Al Dulaimi D.

Gastroenterol Hepatol Bed Bench. 2014 Summer;7(3):186-9.

19.

Barrett's esophagus: its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux.

Sarr MG, Hamilton SR, Marrone GC, Cameron JL.

Am J Surg. 1985 Jan;149(1):187-93.

PMID:
3966636
20.

Risk stratification of Barrett's esophagus: updated prospective multivariate analysis.

Weston AP, Sharma P, Mathur S, Banerjee S, Jafri AK, Cherian R, McGregor D, Hassanein RS, Hall M.

Am J Gastroenterol. 2004 Sep;99(9):1657-66.

PMID:
15330898
Items per page

Supplemental Content

Write to the Help Desk